High level of participation in the warrant program for employees in Hemfosa Fastigheter AB

Report this content

In accordance with the decision of the Annual General Meeting on 25 April 2017, Hemfosa Fastigheter AB has implemented a directed issue of warrants as part of a long-term incentive program. The offer comprises all employees within Hemfosa.

In total 52 employees have acquired a total of 1,294,000 warrants, which corresponds to 89 per cent of the maximum number of warrants pursuant to the decision of the Annual General Meeting.

"It is gratifying that so many of our employees have chosen to participate and to acquire a potential future shareholding in the company, which shows a strong confidence in the continued development of Hemfosa." says Bengt Kjell, Chairman of the Board of Directors.

According to the decision of the Annual General Meeting, each warrants entitles the holder to subscribe for one ordinary share in Hemfosa during two periods between 1 May 2022 and 31 August 2022, the subscription price has been set at SEK 98.40 and the warrant premium has been set at SEK 3.84. Hemfosa will, under certain conditions, subsidize the participants’ premium through a cash bonus, equivalent to but not more than the guaranteed number of warrants for each person. Such bonuses are paid out with 50 per cent after two years and with 50 per cent after four years.

For more information, please contact:

Bengt Kjell, Chairman of the Board of Directors, tel +46 70 594 53 98

About Hemfosa Fastigheter

Hemfosa is a Swedish property company focusing on community service properties in the Nordic region with its largest tenants being the Swedish state and municipalities. This provides stable cash flows and a healthy yield. In order to create value, Hemfosa also aims to actively participate in the transaction market. As per March 31, 2017, Hemfosa owned properties with a total property value of approximately SEK 36.7 billion, excluding the company’s share of the property value in joint ventures. The company’s ordinary share has been listed since March 2014, and the preference share since December 2014, both on Nasdaq Stockholm. Read more at www.hemfosa.se.

Tags:

Documents & Links